A Five Year Randomized Controlled Trial to Assess the Efficacy and Antibody Responses to a Commercial and Autogenous Vaccine for the Prevention of Infectious Bovine Keratoconjunctivitis

A Five Year Randomized Controlled Trial to Assess the Efficacy and Antibody Responses to a Commercial and Autogenous Vaccine for the Prevention of Infectious Bovine Keratoconjunctivitis

A randomized control trial was performed over a five-year period to assess the efficacy and antibody response induced by autogenous and commercial vaccine formulations against infectious bovine keratoconjunctivitis (IBK). Calves were randomly assigned each year to one of three arms: an autogenous va...

Full description

Bibliographic Details
Main Authors: Matthew M. Hille, Matthew L. Spangler, Michael L. Clawson, Kelly D. Heath, Hiep L. X. Vu, Rachel E. S. Rogers, John Dustin Loy
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Vaccines
Subjects:
bovine pinkeye
vaccine
<i>Moraxella bovis</i>
<i>Moraxella bovoculi</i>
<i>Mycoplasma bovoculi</i>
infectious bovine keratoconjunctivitis
Online Access:https://www.mdpi.com/2076-393X/10/6/916

Internet

https://www.mdpi.com/2076-393X/10/6/916

Similar Items